1. Classical Swine Fever Vaccine
2.
Sheep Pox Vaccine
These vaccines are the first that have been developed within the country by using locally isolated strains, a step towards making India self-sufficient, Atmanirbhar, for the country s requirement of Classical Swine Fever Vaccine and Sheep Pox Vaccine.
The agreements were signed on 26 March 2021, followed with a virtual ceremony that took place on 7 April 2021. The technologies were developed by ICAR-IVRI and the commercialization of the technologies was facilitated by Agrinnovate India, a company owned by Department of Agricultural, Research & Education (DARE), Ministry of Agriculture, Government of India.
Both the vaccines have been extensively tested by IVRI for safety and potency and have been found to provide 100% protection.
The domestic equity benchmarks ended with minor gains on Thursday, rising for the third straight session. Metal stocks surged while banks and financials corrected. The Nifty closed below the 14,900 mark.
The barometer index, the S&P BSE Sensex, gained 84.45 points or 0.17% to 49,746.21. The Nifty 50 index rallied 54.75 points or 0.37% to 14,873.80.
The Sensex rose 1.19% and the Nifty climbed 1.61% in three consecutive sessions.
The broader market outperformed the benchmarks on Thursday. The BSE Mid-Cap index rose 0.60% and the BSE Small-Cap index added 0.73%.
The market breadth was strong. On the BSE, 1,857 shares rose and 1,061 shares fell. A total of 167 shares were unchanged.
Investors risk appetite improved after the minutes of last month s meeting of the U.S. Federal Reserve suggested that Fed officials were united on the need to see more progress on economic recovery before scaling back their bond-buying program.
Nifty, Sensex heading higher – Thursday closing report
Moneylife Digital Team
0
We had mentioned in Wednesday’s closing report that Nifty, Sensex continue to trend up. On Thursday, the indices opened higher and closed with decent gains. On the NSE, there were 1,237 advances, 705 declines and 87 unchanged.
The trends of the major indices in the course of Thursday’s trading are given in the table below:
Infosys won a contract for digital transformation of steel maker ArcelorMittal s IT operations. Infosys will work with the London-based steel and mining firm s European arm and share its best practice to optimise, stabilise and transform its IT landscape.
Hester Biosciences jumped 8.79% to Rs 2190 after the company signed agreement with ICAR-IVRI (Indian Council Of Agri Research - Indian Veterinary Research Institute) for classical swine fever & sheep pox vaccines.
In a regulatory filing made during market hours today, the company said that the agreements are for acquiring technologies for the production and commercialisation of classical swine fever vaccine & sheep pox vaccine.
The technologies were developed by ICAR-IVRI and the commercialization of the technologies was facilitated by Agrinnovate India, a company owned by Department of Agricultural, Research & Education (DARE), Ministry of Agriculture, Government of India.
Both the vaccines have been extensively tested by IVRI for safety and potency and have been found to provide 100% protection.
ICAR-IVRI transfers Technology – CSF & Sheep Pox Vaccine through Agrinnovate indiaeducationdiary.in - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from indiaeducationdiary.in Daily Mail and Mail on Sunday newspapers.